TechCN

ZyVersa Therapeutics to Participate in a Fireside Chat at

CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease,......